CalciMedica, Inc. — Key Metrics
2 years of history · ending 2025-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
Z-Score (Altman; <1.81 = distress)
Per Share Metrics
Expense Ratios
Working Capital Analysis
Valuation Multiples
Enterprise Value Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
Capital Deployment Yields
Liquidity & Leverage Ratios
Earnings Quality (OCF/NI · FCF/NI · Sloan Accruals)
EPS (Diluted)
$-2
Book Value Per Share
$-0
Free Cash Flow Per Share
$-1
Cash Per Share
$1
Revenue Per Share
$0
OCF Per Share
$-1
Return on Equity
-761.0%
Return on Assets
-177.1%
Return on Invested Capital
-470.2%
Current Ratio
3.58
Quick Ratio
3.58
Asset Turnover
0.04
R&D / Revenue
2136.6%
SBC / Revenue
416.7%
Capex / Revenue
3.9%
Working Capital
$10M
Net Current Asset Value
$-7M
Invested Capital
$-7M
OCF / Net Income
0.72
FCF / Net Income
0.72
Accruals Ratio (Sloan)
-61.7%
Net Debt
$-13M
Net Debt / EBITDA
0.56
Interest Coverage
-16.26
Cash Coverage
-14.89
Capex Coverage
-756.36
Tangible Common Equity
$-7M
TCE / Total Assets
-48.9%
NOPAT
$-18M
Cash ROIC
-545.9%
WC / Revenue
1367.2%
Capex / D&A
0.61
Reinvestment Rate
0.1%
Asset Growth vs Revenue Growth
-1.7%
Stock Price (FY-end)
$7
Market Cap
$99M
P/S Ratio
138.74
P/B Ratio
2.76
P/TB Ratio
2.76
Enterprise Value
$86M
EV / Sales
120.49
FCF Yield
-21.4%
Shareholder Yield
-3.0%
R&D Yield
15.4%
Capex Yield
0.0%
Shares Variation (YoY)
33.5%
Beta (5Y)
0.28
Cost of Equity
5.9%
52W High
$7
52W Low
$1
Trailing Return 1Y
131.2%
F-Score (Piotroski)
2.00
Z-Score (Altman)
-21.27
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.